{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:35:49Z","timestamp":1787506549665,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14405-5","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:39:12Z","timestamp":1775122752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer\u2019s disease and mild cognitive impairment in Thailand: a modeling study"],"prefix":"10.1186","volume":"26","author":[{"given":"Pattara","family":"Leelahavarong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthamas","family":"Prawjaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakkanan","family":"Angkab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthamon","family":"Wongkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varalak","family":"Srinonprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorapun","family":"Senanarong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"14405_CR1","unstructured":"World health organization (WHO). Dementia. 2023."},{"issue":"2","key":"14405_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"1","key":"14405_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000515676","volume":"11","author":"PA Dharmasaroja","year":"2021","unstructured":"Dharmasaroja PA, Assanasen J, Pongpakdee S, Jaisin K, Lolekha P, Phanasathit M, et al. Etiology of dementia in Thai patients. Dement Geriatric Cogn Disorders Extra. 2021;11(1):64\u201370.","journal-title":"Dement Geriatric Cogn Disorders Extra"},{"issue":"10","key":"14405_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jval.2019.04.1937","volume":"22","author":"K Kongpakwattana","year":"2019","unstructured":"Kongpakwattana K, Dejthevaporn C, Krairit O, Dilokthornsakul P, Mohan D, Chaiyakunapruk N. A real-world evidence analysis of associations among costs, quality of life, and disease-severity indicators of Alzheimer\u2019s disease in Thailand. Value Health. 2019;22(10):1137\u201345.","journal-title":"Value Health"},{"key":"14405_CR5","volume-title":"Long-term care insurance system: a system suitable for Thailand","author":"W Chandoevwit","year":"2017","unstructured":"Chandoevwit W, Vajragupta Y. Long-term care insurance system: a system suitable for Thailand. Bangkok: Thailand Development Research Institute (TDRI); 2017."},{"key":"14405_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"JC Morris","year":"2001","unstructured":"Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer\u2019s disease. J Mol Neurosci. 2001;17:101\u201318.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"14405_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/187152709787847324","volume":"8","author":"R Tarawneh","year":"2009","unstructured":"Tarawneh R, Holtzman DM. Critical issues for successful immunotherapy in Alzheimer\u2019s disease: development of biomarkers and methods for early detection and intervention. CNS Neurol Disorders-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disorders). 2009;8(2):144\u201359.","journal-title":"CNS Neurol Disorders-Drug Targets (Formerly Curr Drug Targets-CNS Neurol Disorders)"},{"key":"14405_CR8","doi-asserted-by":"crossref","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u20135169.","DOI":"10.1002\/alz.13859"},{"key":"14405_CR9","volume-title":"Thai clinical practice guideline for dementia (Full version 2020)","author":"Neurological Institute, Ministry of Public Health","year":"2020","unstructured":"Neurological Institute, Ministry of Public Health. Thai clinical practice guideline for dementia (Full version 2020). Bangkok: Tana; 2020."},{"issue":"1","key":"14405_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000548539","volume":"15","author":"W Nanthasi","year":"2025","unstructured":"Nanthasi W, Rattanabannakit C, Wongkom N, Dujada P, Raksthaput A, Chaichanettee S, et al. The Utility of CSF Biomarkers in Diagnosing Alzheimer\u2019s Disease: A Thai Cohort Study. Dement Geriatric Cogn Disorders Extra. 2025;15(1):162\u201373.","journal-title":"Dement Geriatric Cogn Disorders Extra"},{"key":"14405_CR11","doi-asserted-by":"publisher","first-page":"e102473","DOI":"10.1002\/alz70856_102473","volume":"21","author":"V Senanarong","year":"2025","unstructured":"Senanarong V, Thientunyakit T, Rattanabannakit C, Wongkom N, Dujada P, Raksthaput A, et al. Validation of blood biomarkers for Alzheimer Disease in Thai Cohort. Alzheimer\u2019s Dement. 2025;21:e102473.","journal-title":"Alzheimer\u2019s Dement"},{"key":"14405_CR12","doi-asserted-by":"crossref","unstructured":"Senanarong V, Rattanabannakit C, Nanthasi W, Wongkom N, Dujada P, Phoyoo P, et al. Correlation between blood biomarkers and neuropsychiatric symptoms: Siriraj cohort, Thailand. Alzheimers Dement. 2024;20:e088520.","DOI":"10.1002\/alz.088520"},{"issue":"1","key":"14405_CR13","first-page":"606802","volume":"2010","author":"A Anoop","year":"2010","unstructured":"Anoop A, Singh PK, Jacob RS, Maji SK. CSF Biomarkers for Alzheimer\u2032 s Disease Diagnosis. Int J Alzheimer\u2019s disease. 2010;2010(1):606802.","journal-title":"Int J Alzheimer\u2019s disease"},{"key":"14405_CR14","doi-asserted-by":"crossref","unstructured":"Mattke S, Cho SK, Bittner T, Hl\u00e1vka J, Hanson M. Blood-based biomarkers for Alzheimer\u2019s pathology and the diagnostic process for a disease-modifying treatment: projecting the impact on the cost and wait times. Alzheimers Dement (Amst). 2020;12(1):e12081.","DOI":"10.1002\/dad2.12081"},{"issue":"6","key":"14405_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s12276-021-00638-3","volume":"53","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Park J-C, Jung KS, Kim J, Jang JS, Kwon S, et al. The clinical use of blood-test factors for Alzheimer\u2019s disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit. Exp Mol Med. 2021;53(6):1046\u201354.","journal-title":"Exp Mol Med"},{"issue":"5","key":"14405_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422\u201333.","journal-title":"Lancet Neurol"},{"issue":"10126","key":"14405_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(18)30198-3","volume":"391","author":"V Tangcharoensathien","year":"2018","unstructured":"Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018;391(10126):1205\u201323.","journal-title":"Lancet"},{"key":"14405_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s41669-017-0054-z","volume":"2","author":"TL Michaud","year":"2018","unstructured":"Michaud TL, Kane RL, McCarten JR, Gaugler JE, Nyman JA, Kuntz KM. Using cerebrospinal fluid biomarker testing to target treatment to patients with mild cognitive impairment: a cost-effectiveness analysis. PharmacoEconomics-open. 2018;2:309\u201323.","journal-title":"PharmacoEconomics-open"},{"issue":"3","key":"14405_CR19","doi-asserted-by":"publisher","first-page":"103911","DOI":"10.1016\/j.drudis.2024.103911","volume":"29","author":"K Noda","year":"2024","unstructured":"Noda K, Lim Y, Goto R, Sengoku S, Kodama K. Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer\u2019s disease diagnosis. Drug Discovery Today. 2024;29(3):103911.","journal-title":"Drug Discovery Today"},{"issue":"3","key":"14405_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1258\/135581902760082517","volume":"7","author":"M Gulliford","year":"2002","unstructured":"Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech R, et al. What does \u2018access to health care\u2019 mean? J Health Serv Res Policy. 2002;7(3):186\u20138.","journal-title":"J Health Serv Res Policy"},{"issue":"9984","key":"14405_CR21","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"6","key":"14405_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimer\u2019s Dement. 2013;9(6):657\u201365.","journal-title":"Alzheimer\u2019s Dement"},{"key":"14405_CR23","first-page":"S4","volume":"97","author":"U Chaikledkaew","year":"2014","unstructured":"Chaikledkaew U, Kittrongsiri K. Guidelines for health technology assessment in Thailand (second edition)-the development process. J Med Assoc Thai. 2014;97:S4\u20139.","journal-title":"J Med Assoc Thai"},{"key":"14405_CR24","unstructured":"Bureau of Trade and Economic indices, Ministry of Commerce. Report for consumer price index of Thailand in 2022: Base year 2019 2022 [cited 2023 Feb 8]."},{"key":"14405_CR25","unstructured":"Faculty of Medicine Siriraj Hospital Mahidol University. Announcement from the Faculty of Medicine Siriraj Hospital Mahidol University, Subject: Laboratory service rates, Issue 19\/2014. 2014."},{"key":"14405_CR26","unstructured":"The Comptroller General\u2019s Department. Public health service rates for use in reimbursement of government medical expenses, Sect.\u00a0 8: diagnostic and radiological treatment fees, dated 7 August 2019. 2019 [cited 2024 January 17]. Available from: https:\/\/ww2.chi.or.th\/dataupload\/doccenter\/W376.pdf."},{"issue":"1","key":"14405_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-13-3","volume":"13","author":"V Senanarong","year":"2013","unstructured":"Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, et al. The dementia and disability project in Thai elderly: rational, design, methodology and early results. BMC Neurol. 2013;13(1):1\u201311.","journal-title":"BMC Neurol"},{"key":"14405_CR28","volume-title":"Validation study and economic study of the diagnosis of Alzheimer disease and other neurodegenerative dementia by utilizing blood biomarkers with Single-molecule array (Simoa) technology in Thai cohort (VAB)","author":"V Senanarong","year":"2024","unstructured":"Senanarong V, Rattanabannakit C, Cheiwvit P, Vichianin Y, Hunnangkul S. Validation study and economic study of the diagnosis of Alzheimer disease and other neurodegenerative dementia by utilizing blood biomarkers with Single-molecule array (Simoa) technology in Thai cohort (VAB). Bangkok, Thailand: Division of Neurology, Department of Medicine, Mahidol University; 2024."},{"key":"14405_CR29","doi-asserted-by":"publisher","first-page":"153331752110122","DOI":"10.1177\/15333175211012235","volume":"36","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Natale G, Clouston S. Incidence of mild cognitive impairment, conversion to probable dementia, and mortality. Am J Alzheimer\u2019s Disease Other Dementias\u00ae. 2021;36:15333175211012235.","journal-title":"Am J Alzheimer\u2019s Disease Other Dementias\u00ae"},{"issue":"11","key":"14405_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s40273-020-00937-z","volume":"38","author":"R Gidwani","year":"2020","unstructured":"Gidwani R, Russell LB. Estimating transition probabilities from published evidence: a tutorial for decision modelers. PharmacoEconomics. 2020;38(11):1153\u201364.","journal-title":"PharmacoEconomics"},{"issue":"3","key":"14405_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/gps.1076","volume":"19","author":"JL Fuh","year":"2004","unstructured":"Fuh JL, Pwu RF, Wang SJ, Chen YH. Measuring Alzheimer\u2019s disease progression with transition probabilities in the Taiwanese population. Int J Geriatr Psychiatry. 2004;19(3):266\u201370.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"14405_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0272989X03255922","volume":"23","author":"AH Briggs","year":"2003","unstructured":"Briggs AH, Ades A, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making. 2003;23(4):341\u201350.","journal-title":"Med Decis Making"},{"issue":"5","key":"14405_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","volume":"18","author":"J Pattanaphesaj","year":"2018","unstructured":"Pattanaphesaj J, Thavorncharoensap M, Ramos-Go\u00f1i JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L Valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018;18(5):551\u20138.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"14405_CR34","first-page":"59","volume":"91","author":"S Limwattananon","year":"2011","unstructured":"Limwattananon S. Handling uncertainty of the economic evaluation result: sensitivity analysis. J Med Assoc Thai. 2011;91(6):59.","journal-title":"J Med Assoc Thai"},{"key":"14405_CR35","unstructured":"World Health Organization. Global Health Expenditure database 2022 [cited 2026 Feb 24]. Available from: https:\/\/apps.who.int\/nha\/database\/"},{"issue":"6","key":"14405_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/S0266462319000321","volume":"35","author":"P Leelahavarong","year":"2019","unstructured":"Leelahavarong P, Doungthipsirikul S, Kumluang S, Poonchai A, Kittiratchakool N, Chinnacom D, et al. Health Technology Assessment in Thailand: Institutionalization and Contribution to Healthcare Decision Making: Review of Literature. Int J Technol Assess Health Care. 2019;35(6):467\u201373.","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"14405_CR37","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3233\/JAD-170324","volume":"60","author":"RL Handels","year":"2017","unstructured":"Handels RL, Wimo A, Dodel R, Kramberger MG, Visser PJ, Molinuevo JL, et al. Cost-utility of using Alzheimer\u2019s disease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia. J Alzheimers Dis. 2017;60(4):1477\u201387.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"14405_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jalz.2010.07.001","volume":"8","author":"D Getsios","year":"2012","unstructured":"Getsios D, Blume S, Ishak KJ, Maclaine G, Hern\u00e1ndez L. An economic evaluation of early assessment for Alzheimer\u2019s disease in the United Kingdom. Alzheimer\u2019s Dement. 2012;8(1):22\u201330.","journal-title":"Alzheimer\u2019s Dement"},{"key":"14405_CR39","unstructured":"National drug information, National drug policy division. Announcement of the national drug system development board on determining the median price of medicines 2019, announced on 05 April 2019. 2019 [cited 2024 Jan 15]. Available from: https:\/\/ndi.fda.moph.go.th\/drug_price."},{"key":"14405_CR40","unstructured":"Drug and medical supply information center. Ministry of public health. Drug price 2024 [cited 2024 Jan 15]. Available from: https:\/\/dmsic.moph.go.th\/index\/drugsearch\/3."},{"issue":"4","key":"14405_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.kjms.2011.10.025","volume":"28","author":"Y-C Yeh","year":"2012","unstructured":"Yeh Y-C, Ouyang W-C. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review. Kaohsiung J Med Sci. 2012;28(4):185\u201393.","journal-title":"Kaohsiung J Med Sci"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14405-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:33:35Z","timestamp":1778657615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14405-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14405"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14405-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the ethics committee of the Siriraj Hospital Institutional Review Board (reference: Si 196\/2023), and being in compliance with the Helsinki Declaration. All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"685"}}